Vitamin D and genetic ancestry are associated with apoptosis rates in benign and malignant prostatic epithelium

Vitamin D metabolites may be protective against prostate cancer (PCa). We conducted a cross‐sectional analysis to evaluate associations between in vivo vitamin D status, genetic ancestry, and degree of apoptosis using prostatic epithelial terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining.

[1]  Jingxuan Chen,et al.  Vitamin D and its analogs as anticancer and anti-inflammatory agents. , 2020, European journal of medicinal chemistry.

[2]  Joshua D. Campbell,et al.  Genomic Profiling of Prostate Cancers from Men with African and European Ancestry , 2020, Clinical Cancer Research.

[3]  William E Grizzle,et al.  Self‐Identified African Americans and prostate cancer risk: West African genetic ancestry is associated with prostate cancer diagnosis and with higher Gleason sum on biopsy , 2019, Cancer medicine.

[4]  Prashanth Rawla,et al.  Epidemiology of Prostate Cancer , 2019, World journal of oncology.

[5]  M. Stampfer,et al.  Circulating 25‐hydroxyvitamin D, vitamin D binding protein and risk of advanced and lethal prostate cancer , 2018, International journal of cancer.

[6]  D. Moreira,et al.  Prostate cancer disparities in Hispanics by country of origin: a nationwide population-based analysis , 2018, Prostate Cancer and Prostatic Diseases.

[7]  P. Cheriyath,et al.  Prevalence of Vitamin D Deficiency and Associated Risk Factors in the US Population (2011-2012) , 2018, Cureus.

[8]  J. Lynch,et al.  Racial differences in the expression of inhibitors of apoptosis (IAP) proteins in extracellular vesicles (EV) from prostate cancer patients , 2017, PloS one.

[9]  A. Pollack,et al.  Ethnic heterogeneity and prostate cancer mortality in Hispanic/Latino men: a population-based study , 2017, Oncotarget.

[10]  Mahul B Amin,et al.  Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma , 2017, The American journal of surgical pathology.

[11]  R. Kittles,et al.  Association between Serum 25-Hydroxy-Vitamin D and Aggressive Prostate Cancer in African American Men , 2016, Nutrients.

[12]  R. Kittles,et al.  Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[14]  A. Bera,et al.  Vitamin D in Prostate Cancer. , 2016, Vitamins and hormones.

[15]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[16]  M. A. O. Ignacio,et al.  How to cite this article , 2016 .

[17]  R. Kittles,et al.  Association of Genetic Ancestry with Breast Cancer in Ethnically Diverse Women from Chicago , 2014, PLoS ONE.

[18]  M. Terris,et al.  Multi-institutional validation of the CAPRA-S score to predict disease recurrence and mortality after radical prostatectomy. , 2014, European urology.

[19]  R. Kittles,et al.  Vitamin D Deficiency Predicts Prostate Biopsy Outcomes , 2014, Clinical Cancer Research.

[20]  S. Tretli,et al.  The Inverse Relationship between 25-Hydroxyvitamin D and Cancer Survival: Discussion of Causation , 2013, Cancers.

[21]  Yiran Huang,et al.  Synergistic effect and mechanism of vitamin A and vitamin D on inducing apoptosis of prostate cancer cells , 2013, Molecular Biology Reports.

[22]  E. Garrett-Mayer,et al.  Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. , 2012, The Journal of clinical endocrinology and metabolism.

[23]  K. Jensen,et al.  Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. , 2012, Endocrinology.

[24]  R. Kittles,et al.  Predictors of Serum Vitamin D Levels in African American and European American Men in Chicago , 2012, American journal of men's health.

[25]  M. Leid,et al.  Detection of apoptosis by TUNEL assay. , 2012, Methods in molecular biology.

[26]  Zhentao Zhang,et al.  Dietary Vitamin D and Vitamin D Receptor Level Modulate Epithelial Cell Proliferation and Apoptosis in the Prostate , 2011, Cancer Prevention Research.

[27]  Scott M. Williams,et al.  Blood Vitamin D Levels in Relation to Genetic Estimation of African Ancestry , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[28]  D. Feldman,et al.  Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment. , 2010, Endocrine-related cancer.

[29]  Jun Lu,et al.  Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate‐induced and 5‐aza‐2′‐deoxycytidine‐induced PTEN upregulation , 2010, The FEBS journal.

[30]  Stephen L. Hauser,et al.  Genome-wide patterns of population structure and admixture in West Africans and African Americans , 2009, Proceedings of the National Academy of Sciences.

[31]  R. Langan,et al.  Recognition and management of vitamin D deficiency. , 2009, American family physician.

[32]  Carlos A Camargo,et al.  Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. , 2009, Archives of internal medicine.

[33]  R. Bostick,et al.  Effects of Vitamin D and Calcium Supplementation on Markers of Apoptosis in Normal Colon Mucosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2009, Cancer Prevention Research.

[34]  Gabriel Silva,et al.  Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in America , 2009, Human mutation.

[35]  J. Michael Gaziano,et al.  A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer , 2007, PLoS medicine.

[36]  D. Trump,et al.  Phase II trial of high‐dose, intermittent calcitriol (1,25 dihydroxyvitamin D3) and dexamethasone in androgen‐independent prostate cancer , 2006, Cancer.

[37]  D. Feldman,et al.  Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer , 2005, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  D. Peehl,et al.  Genistein potentiates the growth inhibitory effects of 1,25-dihydroxyvitamin D3 in DU145 human prostate cancer cells: Role of the direct inhibition of CYP24 enzyme activity , 2005, Molecular and Cellular Endocrinology.

[39]  David Feldman,et al.  Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. , 2005, Cancer research.

[40]  N. Risch,et al.  Genetic admixture and asthma‐related phenotypes in Mexican American and Puerto Rican asthmatics , 2005, Genetic epidemiology.

[41]  C. Corless,et al.  Randomized study of high-dose pulse calcitriol or placebo prior to radical prostatectomy. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[42]  J. Lawry.  Detection of apoptosis by the TUNEL assay. , 2004, Methods in molecular medicine.

[43]  K. Weiss,et al.  Race, ancestry, and genes: implications for defining disease risk. , 2003, Annual review of genomics and human genetics.

[44]  R. Mazess,et al.  Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[45]  M. Serio,et al.  Vitamin D3 analogue inhibits keratinocyte growth factor signaling and induces apoptosis in human prostate cancer cells , 2002, The Prostate.

[46]  P. Hershberger,et al.  Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[47]  S. Cramer,et al.  25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells. , 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[48]  N. Kyprianou,et al.  Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African‐American patients , 2000, The Prostate.

[49]  T. McDonnell,et al.  Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-21. , 2000, Endocrinology.

[50]  T. McDonnell,et al.  Printed in U.S.A. Copyright © 2000 by The Endocrine Society Calcitriol-Induced Apoptosis in LNCaP Cells Is Blocked By Overexpression of Bcl-2* , 1999 .

[51]  T. Stamey,et al.  Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol) , 1998, The Journal of urology.

[52]  G Block,et al.  A Reduced Dietary Questionnaire: Development and Validation , 1990, Epidemiology.

[53]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[54]  L. S. Minckler.  Racial Differences , 1924, Science.